# Re-Irradiation With Proton Beam Therapy for Localized Perineural Spread Following Presacral Recurrence in Sigmoid Colon Cancer: A Case Report

**Authors:** Masahiko Harada, Takashi Saito, Toshiki Ishida, Yutaro Mori, Hideyuki Sakurai

PMC · DOI: 10.7759/cureus.56765 · 2024-03-23

## TL;DR

A patient with recurring colon cancer near the sacrum was successfully treated with proton beam therapy twice, showing its potential for managing nerve-related cancer spread.

## Contribution

Demonstrates the potential of re-irradiation with proton beam therapy for localized perineural spread in presacral recurrence of colon cancer.

## Key findings

- Re-irradiation with PBT was effective in managing localized perineural spread after presacral recurrence.
- The patient remained recurrence-free for 1.5 years following re-irradiation.
- Dosage to adjacent organs was minimized during re-irradiation planning.

## Abstract

This report describes the effective management of localized perineural spread (PNS) to the sacral peripheral nerves following a presacral recurrence of colon cancer using proton beam therapy (PBT). The patient, a male in his 60s with a history of sigmoid colon cancer treated with laparoscopic Hartmann's procedure, presented with presacral recurrence two years post-surgery. Radical resection was deemed infeasible, leading to a combined treatment of PBT (75 Gy relative biological effectiveness (RBE) in 25 fractions) and capecitabine. However, three years post-PBT, magnetic resonance imaging revealed swelling of the left S2 nerve with abnormal fluorodeoxyglucose uptake, indicating localized PNS. Re-irradiation with PBT (75 Gy RBE in 25 fractions) was conducted, carefully considering the overlap with the previous PBT field and aiming to minimize dosage to adjacent organs. At 1.5 years post-reirradiation, the patient remained free of recurrence. This case underscores the potential efficacy of PBT and emphasizes the need for further research to assess its broader applicability in comparable situations.

## Linked entities

- **Chemicals:** capecitabine (PubChem CID 60953), fluorodeoxyglucose (PubChem CID 53716604)
- **Diseases:** colon cancer (MONDO:0002032), sigmoid colon cancer (MONDO:0001464)

## Full-text entities

- **Diseases:** swelling of (MESH:D004487), Sigmoid Colon Cancer (MESH:D012811), nerve (MESH:C537568), colon cancer (MESH:D015179)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11034400/full.md

---
Source: https://tomesphere.com/paper/PMC11034400